Federal Register / Vol. 87, No. 64 / Monday, April 4, 2022 / Notices 19517 

comment or supporting materials that 

you consider confidential or 

inappropriate for public disclosure. If 

you include your name, contact 

information, or other information that 

identifies you in the body of your 

comments, that information will be on 

public display. CDC will review all 

submissions and may choose to redact, 

or withhold, submissions containing 

private or proprietary information such 

as Social Security numbers, medical 

information, inappropriate language, or 

duplicate/near duplicate examples of a 

mass-mail campaign. Do not submit 

comments by email. CDC does not 

accept comments by email. 

Background and Brief Description 

Hepatitis B virus (HBV) is transmitted 

via blood or sexual contact. Persons 

with chronic HBV infection are at 

increased risk for cirrhosis and liver 

cancer and require medical care 

(Schillie et al., 2018). National health 

survey data indicate that about 880,000 

people were living with HBV infection 

in the United States during 2013–2018, 

with modeled data putting that estimate 

at 1.89 million (Roberts, Ly, et al., 2021; 

Wong et al., 2021). Testing is the first 

step in accessing treatment, but an 

estimated two-thirds of people living 

with hepatitis B in the United States 

during 2013–2018 were unaware of their 

HBV infection (Kim et al., 2013). 

Despite the availability of highly 

effective hepatitis B vaccines that can 

prevent development of subsequent 

acute and chronic liver disease, 70 

percent of adults in the United States 

self-reported they were unvaccinated as 

of 2018 (Lu et al., 2021). National 

surveillance data reveal that during 

2011–2019, rates of reported acute 

hepatitis B steadily increased among 

persons aged 40–49 and 50–59 years 

(CDC Viral Hepatitis Surveillance, 

2021). Among the acute HBV cases 

reported to CDC in 2019, injection drug 

use was the most common risk factor 

(CDC Viral Hepatitis Surveillance, 

2021). Rates of newly reported chronic 

hepatitis B were highest among persons 

aged 30–49 years, Asian/Pacific Islander 

persons, and Black/African American 

persons in 2019 (CDC Viral Hepatitis 

Surveillance, 2021). Providing a 

framework to reach the World Health 

Organization (WHO) viral hepatitis 

elimination goals, the Viral Hepatitis 

National Strategic Plan for the United 

States calls for an increase in the 

proportion of people with HBV 

infection who are aware of their 

infection from a baseline of 32 percent 

during 2013–2016 to 90 percent by 2030 

(Department of Health and Human 

Services, 2020). In support of this goal, 

CDC used current evidence to update its 

previous 2008 recommendations for 

testing and management for people with 

chronic hepatitis B in the United States. 

As described in the recommendation 

document found in the Supporting and 

Related Materials tab of the docket, 

these recommendations supplement 

previously published CDC 

recommendations for testing and 

identifying persons with chronic HBV 

infection in the United States published 

in 2008 (Weinbaum et al., 2008). They 

do so by adding hepatitis B screening at 

least once in a lifetime for persons aged 

18 years of age and older and specifying 

the use of the three-test panel during 

screening to identify persons who: (1) 

Have a current HBV infection, (2) have 

resolved infection and who may be 

susceptible to reactivation, (3) are 

susceptible and need vaccination, or (4) 

are vaccinated. 

Dated: March 30, 2022. 

Angela K. Oliver, 

Executive Secretary, Centers for Disease 

Control and Prevention. 

[FR Doc. 2022–07050 Filed 4–1–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifiers: CMS–P–0015A and 

CMS–10394] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including the necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions, the accuracy of 

the estimated burden, ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and the use 

of automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

DATES: Comments on the collection(s) of 

information must be received by the 

OMB desk officer by May 4, 2022. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ website address at 

website address at: https://

www.cms.gov/Regulations-andGuidance/Legislation/Paperwork

ReductionActof1995/PRA-Listing.html. 

FOR FURTHER INFORMATION CONTACT: 

William Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. The term ‘‘collection of 

information’’ is defined in 44 U.S.C. 

3502(3) and 5 CFR 1320.3(c) and 

includes agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. Section 

3506(c)(2)(A) of the PRA (44 U.S.C. 

3506(c)(2)(A)) requires federal agencies 

to publish a 30-day notice in the 

Federal Register concerning each 

proposed collection of information, 

including each proposed extension or 

reinstatement of an existing collection 

of information, before submitting the 

collection to OMB for approval. To 

comply with this requirement, CMS is 

publishing this notice that summarizes 

the following proposed collection(s) of 

information for public comment: 

1. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Medicare 

Current Beneficiary Survey (MCBS); 

Use: CMS is the largest single payer of 

health care in the United States. The 

agency plays a direct or indirect role in 

administering health insurance coverage 

for more than 120 million people across 


khammond on DSKJM1Z7X2PROD with NOTICES
19518 Federal Register / Vol. 87, No. 64 / Monday, April 4, 2022 / Notices 

the Medicare, Medicaid, CHIP, and 

Exchange populations. A critical aim for 

CMS is to be an effective steward, major 

force, and trustworthy partner in 

supporting innovative approaches to 

improving quality, accessibility, and 

affordability in healthcare. CMS also 

aims to put patients first in the delivery 

of their health care needs. 

The Medicare Current Beneficiary 

Survey (MCBS) is the most 

comprehensive and complete survey 

available on the Medicare population 

and is essential in capturing data not 

otherwise collected through our 

operations. The MCBS is a nationallyrepresentative, longitudinal survey of 

Medicare beneficiaries that we sponsor 

and is directed by the Office of 

Enterprise Data and Analytics (OEDA). 

MCBS data collection includes both inperson and phone interviewing. The 

survey captures beneficiary information 

whether aged or disabled, living in the 

community or facility, or serviced by 

managed care or fee-for-service. Data 

produced as part of the MCBS are 

enhanced with our administrative data 

(e.g., fee-for-service claims, prescription 

drug event data, enrollment, etc.) to 

provide users with more accurate and 

complete estimates of total health care 

costs and utilization. The MCBS has 

been continuously fielded for more than 

30 years, encompassing over 1.2 million 

interviews and more than 140,000 

survey participants. Respondents 

participate in up to 11 interviews over 

a four-year period. This gives a 

comprehensive picture of health care 

costs and utilization over a period of 

time. 

The MCBS continues to provide 

unique insight into the Medicare 

program and helps CMS and our 

external stakeholders better understand 

and evaluate the impact of existing 

programs and significant new policy 

initiatives. In the past, MCBS data have 

been used to assess potential changes to 

the Medicare program. For example, the 

MCBS was instrumental in supporting 

the development and implementation of 

the Medicare prescription drug benefit 

by providing a means to evaluate 

prescription drug costs and out-ofpocket burden for these drugs to 

Medicare beneficiaries. Beginning in 

2023, this proposed revision to the 

clearance will add a few new measures 

to existing questionnaire sections and 

will remove COVID–19-related content 

that is no longer relevant for 

administration. New respondent 

materials are also included in this 

request. The revisions will result in a 

net decrease in respondent burden as 

compared to the current clearance due 

to the removal of COVID–19 items. 

Form Number: CMS–P–0015A (OMB: 

0938–0568); Frequency: Occasionally; 

Affected Public: Business or other forprofits and Not-for-profit institutions; 

Number of Respondents: 13,656; Total 

Annual Responses: 35,998; Total 

Annual Hours: 46,680. (For policy 

questions regarding this collection 

contact William Long at 410–786–7927.) 

2. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Application and 

Triennial Re-application to Be a 

Qualified Entity to Receive Medicare 

Data for Performance Measurement; 

Use: The Patient Protection and 

Affordable Care Act (ACA) was enacted 

on March 23, 2010 (Pub. L. 111–148). 

ACA amends section 1874 of the Social 

Security Act by adding a new 

subsection (e) to make standardized 

extracts of Medicare claims data under 

Parts A, B, and D available to qualified 

entities to evaluate the performance of 

providers of services and suppliers. This 

is the application needed to determine 

an organization’s eligibility as a 

qualified entity. The information from 

the collection is used by CMS to 

determine whether an organization 

meets the criteria required to be 

considered a qualified entity to receive 

Medicare claims data under ACA 

Section 10332. CMS evaluates the 

organization’s eligibility in terms of 

organizational and governance 

capabilities, addition of claims data 

from other sources, and data privacy 

and security. This collection covers the 

application through which 

organizations provide information to 

CMS to determine whether they will be 

approved as a qualified entity. This 

collection also covers the triennial reapplication (CMS–10596; 0938–1317) 

through which organizations provide 

information to CMS to determine 

whether they are approved to continue 

as a qualified entity. Form Number: 

CMS–10394 (OMB control number: 

0938–1144); Frequency: Occasionally; 

Affected Public: Not-for-profits 

institutions and Business or other forprofits; Number of Respondents: 30; 

Total Annual Responses: 30; Total 

Annual Hours: 3,800. (For policy 

questions regarding this collection 

contact Kari A. Gaare at 410–786–8612.) 

Dated: March 30, 2022. 

William N. Parham, III, 

Director, Paperwork Reduction Staff, Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2022–07055 Filed 4–1–22; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; Judicial, 

Court, and Attorney Measures of 

Performance (New Collection) 

AGENCY: Children’s Bureau; 

Administration for Children and 

Families; HHS. 

ACTION: Request for public comment. 

SUMMARY: The Children’s Bureau, 

Administration for Children and 

Families (ACF), U.S. Department of 

Health and Human Services (HHS), is 

proposing to collect data for a new 

descriptive study, Judicial, Court, and 

Attorney Measures of Performance 

(JCAMP). 

DATES: Comments due within 30 days of 

publication. The Office of Management 

and Budget (OMB) is required to make 

a decision concerning the collection of 

information between 30 and 60 days 

after publication of this document in the 

Federal Register. Therefore, a comment 

is best assured of having its full effect 

if OMB receives it within 30 days of 

publication. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. You can also obtain 

copies of the proposed collection of 

information by emailing infocollection@

acf.hhs.gov. Identify all emailed 

requests by the title of the information 

collection. 

SUPPLEMENTARY INFORMATION: 

Description: This study will collect 

information from Court Improvement 

Program (CIP) staff to (1) understand 

data capacity and current use of 

performance measures and (2) gather 

feedback from the performance measure 

pilot process. This will be accomplished 

using two instruments: 

JCAMP CIP Data Capacity Survey 

The survey asks CIPs about their 

current capacity to collect specific data 

elements from the following six 

categories of measurement: (1) Legal and 

judicial context (e.g., court docketing), 

(2) Practices (e.g., attorney pre-petition 

legal practice), (3) Short-term outcomes 

that happen during hearings (e.g., 

discussion of key issues), (4) 

Intermediate outcomes that happen 


khammond on DSKJM1Z7X2PROD with NOTICES